| Notices |
This is a discussion on Pathogen Inactivation/Reduction within the Ask a Professional forum; Hi, This is my first post. I work with a company that makes a pathogen ...
|
|||
|
Hi,
This is my first post. I work with a company that makes a pathogen inactiation technology approved and used in Europe. I'm trying to better understand the US market and the slow adoption here. Is anyone familiar with pathogen inactivation/reduction and if so, what are your thoughts on it i.e. benefits, concerns, reasons why its not approved/used here. Thanks |
![]() |
| Tags |
| bacteria, blood, contaminated, fda, pathogen |
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Resistance of viruses to inactivation in blood products | David Ampleford | Medical Articles and Abstracts | 0 | 11-08-2006 11:37 PM |
| Reduction of postoperative spinal infections based on an etiologic protocol. | Sharon Grant | Medical Articles and Abstracts | 0 | 10-07-2006 10:06 PM |
| Reduction of blood flow to skin | Editors | Glossary of Terms | 0 | 11-29-2003 03:30 PM |
| Pathogen Reduction and Blood Component Safety | Jan B. Wade | News and Hot Topics such as Hepatitis C, SARS and AIDS | 0 | 07-31-2003 12:53 PM |